Atosiban Labatec 6.75 mg / 0.9 ml
Atosiban Labatec 6.75 mg / 0.9 ml is a medicine authorised by Swissmedic under authorisation number 69185. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 March 2024 and the authorisation is limited until 03 March 2029. ATC code G02CX01 places the medicine in the group Other gynecologicals.
| Authorisation number | 69185 |
|---|---|
| Name | Atosiban Labatec 6.75 mg / 0.9 ml |
| Full name | Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G02CX01 |
| First authorisation | 04 March 2024 |
| Authorisation validity | 03 March 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Atosiban Labatec 6.75 mg / 0.9 ml, solution injectable | B | 04 March 2024 |
| 2 | Atosiban Labatec 37.5 mg / 5 ml, solution à diluer pour perfusion | B | 04 March 2024 |
| 3 | Atosiban Labatec 75 mg / 10 ml, solution à diluer pour perfusion | B | 04 March 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | G02CX01 | 09.01.2. | B |
| 2 | 1 | Durchstechflasche(n) | G02CX01 | 09.01.2. | B |
| 3 | 1 | Durchstechflasche(n) | G02CX01 | 09.01.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Atosiban Labatec 6.75 mg / 0.9 ml authorised in Switzerland?
Yes. Atosiban Labatec 6.75 mg / 0.9 ml is authorised by Swissmedic under authorisation number 69185, data as of 01 September 2026. The authorisation is limited until 03 March 2029.
Which dispensing category does Atosiban Labatec 6.75 mg / 0.9 ml have?
Atosiban Labatec 6.75 mg / 0.9 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Atosiban Labatec 6.75 mg / 0.9 ml?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.